Balyasny Asset Management LLC Tg Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$13.32 - $19.19 $10.7 Million - $15.4 Million	802,003 New	802,003 $14.3 Million
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $1.86 Million - $5.24 Million	278,756 Added 190.48%	425,099 $7.26 Million
Q3 2023 Nov 14, 2023	SELL	$8.36 - $26.5 $4.77 Million - $15.1 Million	-570,621 Reduced 79.59%	146,343 $1.22 Million
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $5.6 Million - $12.7 Million	361,716 Added 101.82%	716,964 $17.8 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $19.34 $3.63 Million - $6.87 Million	355,248 New	355,248 $5.34 Million
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $47,980 - $88,191	10,499 New	10,499 $62,000
Q2 2022 Aug 15, 2022	SELL	$3.74 - $10.66 $2.18 Million - $6.2 Million	-581,587 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.81 - $20.45 $2.46 Million - $6.45 Million	315,411 Added 118.5%	581,587 $5.53 Million
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $4.05 Million - $9.45 Million	266,176 New	266,176 $5.06 Million
Q2 2020 Aug 14, 2020	SELL	$8.9 - $21.84 $228,792 - $561,440	-25,707 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.14 - $15.99 $183,547 - $411,054	25,707 New	25,707 $253,000
Q4 2018 Feb 14, 2019	SELL	$3.44 - $5.76 $352,844 - $590,808	-102,571 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.15 - $14.0 $260,131 - $707,154	50,511 Added 97.02%	102,571 $574,000
Q2 2018 Aug 14, 2018	BUY	$12.5 - $15.0 $650,750 - $780,900	52,060 New	52,060 $685,000

336

87.6M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.23B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.